KCT0002589招募中未知
Cholera vaccination as a model to measure the inflammatory response in the gut: A case of modulation with a Lactobacillus plantarum K8 lysate
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 50(Year)(—)
- 性别
- Male
入选标准
- •1) Subject who voluntarily agrees to participate and sign in informed consent form
- •2) 20 years= Age = 50 years
- •4) Healthy bowel habit
- •5) Availability of internet connection
- •6) Smart phone user
排除标准
- •1) Previous cholera vaccination.
- •2) Other vaccination in the past 1 month.
- •3) Acute gastroenteritis in the past 2 months.
- •4) Use of antibiotics in the past 2 months.
- •5) Hypersensitivity to the vaccine, to formaldehyde, to any of the excipients (sodium salts) or to probiotics.
- •6) Disease of GI tract (constipation, diarrhea, IBD, etc), liver, gall bladder, kidneys, thyroid gland.
- •7) Immune-compromised.
- •8) Use of immunosuppressive drugs.
- •9) Drug abuse, and not willing/able to stop this during the study.
- •10) Continuous consumption of probiotics within 2 weeks prior to the study.
- •11) Excessive alcohol usage (140 g/week, about 3.5 bottles/week or 4 glasses/day as soju).
- •12) Participating in another clinical trial within 12 weeks prior to or during the study.
- •13) Visiting a country affected by cholera in the past 1 month.
研究者
相似试验
尚未招募
不适用
Effect of vaccination in Covid-19 patients requring ICU admissioCTRI/2023/01/049142Dr Amarja Ashok Havaldar
已完成
不适用
Introduction of Cholera Vaccine in BangladeshCholeraNCT01339845International Centre for Diarrhoeal Disease Research, Bangladesh240,000
已完成
不适用
Immunological Characteristics of a Population at Risk of Cholera After Oral Cholera Vaccine (CHOVAXIM)Diarrhea InfectiousNCT04423159Centre for Infectious Disease Research in Zambia225
招募中
不适用
Vaccine- and Infection-derived Correlates of Protection for CholeraCholeraNCT06455852Massachusetts General Hospital1,221
已完成
4 期
Effect of Extended Dose Intervals on the Immune Response to Oral Cholera VaccineVibrio Cholerae InfectionCholeraNCT03373669Johns Hopkins Bloomberg School of Public Health120
